Pfizer Loses Drawn-Out Battle Over Generic Neurontin

Law360, New York (August 24, 2005, 12:00 AM EDT) -- A federal judge in New Jersey has ruled in favor of five generic makers in their battle against drug giant Pfizer, Inc. over rights to the epilepsy drug Neurontin.

A judge in the U.S. District Court for the District of New Jersey granted a joint motion for summary judgment filed by the defendants, Alpharma, Teva, Ivax, Apotex, and Eon, in the patent litigation regarding gabapentin, the generic version of Neurontin.

The court ruled that the defendants are entitled to summary judgment of non-infringement based on Pfizer's...
To view the full article, register now.